+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tinea Pedis (Athlete`s Foot) Treatment: Global Strategic Business Report

  • PDF Icon

    Report

  • 284 Pages
  • April 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1382365

Global Tinea Pedis (Athlete`s Foot) Treatment Market to Reach $1.3 Billion by 2030

The global market for Tinea Pedis (Athlete`s Foot) Treatment estimated at US$983.8 Million in the year 2022, is projected to reach a revised size of US$1.3 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2022-2030. Topical, one of the segments analyzed in the report, is projected to record 3.3% CAGR and reach US$756.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Oral segment is readjusted to a revised 2.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $268 Million, While China is Forecast to Grow at 5.2% CAGR

The Tinea Pedis (Athlete`s Foot) Treatment market in the U.S. is estimated at US$268 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$248.4 Million by the year 2030 trailing a CAGR of 5.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.7% and 2.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Select Competitors (Total 43 Featured) -

  • Alva-Amco Pharmacal Companies, Inc.
  • Cipla Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • ProFoot, Inc.
  • Qilu Pharmaceutical Co., Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Taro Pharmaceutical Industries Ltd.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tinea Pedis (Athlete's Foot) Treatment - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 3: World 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 6: World 18-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 9: World 18-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 12: World 18-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 15: World 18-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 18: World 18-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Drug Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Drug Stores by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 21: World 18-Year Perspective for Drug Stores by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 22: World Tinea Pedis (Athlete`s Foot) Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 24: USA Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 25: USA 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: USA Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 28: USA 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 31: Canada 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 34: Canada 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
JAPAN
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 37: Japan 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 40: Japan 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
CHINA
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 42: China Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 43: China 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 45: China Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 46: China 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
EUROPE
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 49: Europe 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 52: Europe 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 55: Europe 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
FRANCE
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 57: France Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 58: France 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 60: France Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 61: France 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
GERMANY
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 64: Germany 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 67: Germany 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 70: Italy 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 73: Italy 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
UNITED KINGDOM
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 75: UK Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 76: UK 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 78: UK Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 79: UK 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 82: Spain 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 85: Spain 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 88: Russia 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 91: Russia 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 94: Rest of Europe 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 97: Rest of Europe 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
ASIA-PACIFIC
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 100: Asia-Pacific 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Topical and Oral Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 103: Asia-Pacific 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Administrative Route - Percentage Breakdown of Value Sales for Topical and Oral for the Years 2012, 2023 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2021 and % CAGR
  • Table 106: Asia-Pacific 18-Year Perspective for Tinea Pedis (Athlete`s Foot) Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Retail Pharmacies, Hospitals, Online Pharmacies and Drug Stores for the Years 2012, 2023 & 2030
AUSTRALIA
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Tinea Pedis (Athlete`s Foot) Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alva-Amco Pharmacal Companies, Inc.
  • Cipla Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • ProFoot, Inc.
  • Qilu Pharmaceutical Co., Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Taro Pharmaceutical Industries Ltd.

Table Information